8-K

Company

Viking Therapeutics, Inc.

Filed

April 14, 2016

Period of Report

April 13, 2016

Accession Number

0001564590-16-016177

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →